Loading clinical trials...
Loading clinical trials...
Pilot Imaging Study With 89Zr-Trastuzumab in HER2-positive Metastatic Breast Cancer Patients : Correlation With FDG-PET/CT and Anatomopathological Results
Conditions
Interventions
Zr89-trastuzumab
Locations
1
Belgium
Jules Bordet Institut
Brussels, Brussels Capital, Belgium
Start Date
August 1, 2011
Primary Completion Date
September 1, 2015
Completion Date
September 1, 2015
Last Updated
April 18, 2017
NCT07225504
NCT06276634
NCT07191730
NCT06797635
NCT06312176
NCT05292664
Lead Sponsor
Jules Bordet Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions